188 related articles for article (PubMed ID: 1447987)
1. Hepatotoxicity from paracetamol self-poisoning in western Sydney: a continuing challenge.
Brotodihardjo AE; Batey RG; Farrell GC; Byth K
Med J Aust; 1992 Sep; 157(6):382-5. PubMed ID: 1447987
[TBL] [Abstract][Full Text] [Related]
2. Risk prediction of hepatotoxicity in paracetamol poisoning.
Wong A; Graudins A
Clin Toxicol (Phila); 2017 Sep; 55(8):879-892. PubMed ID: 28447858
[TBL] [Abstract][Full Text] [Related]
3. Plasma paracetamol concentration at hospital presentation has a dose-dependent relationship with liver injury despite prompt treatment with intravenous acetylcysteine.
Cairney DG; Beckwith HK; Al-Hourani K; Eddleston M; Bateman DN; Dear JW
Clin Toxicol (Phila); 2016 Jun; 54(5):405-10. PubMed ID: 27108714
[TBL] [Abstract][Full Text] [Related]
4. Predicting the requirement for N-acetylcysteine in paracetamol poisoning from reported dose.
Duffull SB; Isbister GK
Clin Toxicol (Phila); 2013; 51(8):772-6. PubMed ID: 23964853
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of the paracetamol-aminotransferase multiplication product to predict hepatotoxicity in modified-release paracetamol overdose.
Wong A; Sivilotti MLA; Graudins A
Clin Toxicol (Phila); 2017 Jun; 55(5):346-351. PubMed ID: 28421844
[TBL] [Abstract][Full Text] [Related]
6. The administration of N-acetylcysteine causes a decrease in prothrombin time in patients with paracetamol overdose but without evidence of liver impairment.
Lucena MI; López-Torres E; Verge C; Andrade RJ; Puche MJ; Seoane J; de la Cuesta FS
Eur J Gastroenterol Hepatol; 2005 Jan; 17(1):59-63. PubMed ID: 15647642
[TBL] [Abstract][Full Text] [Related]
7. Massive paracetamol overdose: an observational study of the effect of activated charcoal and increased acetylcysteine dose (ATOM-2).
Chiew AL; Isbister GK; Kirby KA; Page CB; Chan BSH; Buckley NA
Clin Toxicol (Phila); 2017 Dec; 55(10):1055-1065. PubMed ID: 28644687
[TBL] [Abstract][Full Text] [Related]
8. External validation of the paracetamol-aminotransferase multiplication product to predict hepatotoxicity from paracetamol overdose.
Wong A; Sivilotti ML; Dargan PI; Wood DM; Greene SL
Clin Toxicol (Phila); 2015; 53(8):807-14. PubMed ID: 26175095
[TBL] [Abstract][Full Text] [Related]
9. Paracetamol metabolite concentrations following low risk overdose treated with an abbreviated 12-h versus 20-h acetylcysteine infusion.
Wong A; Homer N; Dear JW; Choy KW; Doery J; Graudins A
Clin Toxicol (Phila); 2019 May; 57(5):312-317. PubMed ID: 30453788
[TBL] [Abstract][Full Text] [Related]
10. Acetaminophen/diphenhydramine overdose in profound hypothermia.
Rollstin AD; Seifert SA
Clin Toxicol (Phila); 2013 Jan; 51(1):50-3. PubMed ID: 23194005
[TBL] [Abstract][Full Text] [Related]
11. Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N-acetylcysteine for paracetamol overdose-the PP100-01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial.
; Dear J
Trials; 2019 Jan; 20(1):27. PubMed ID: 30621764
[TBL] [Abstract][Full Text] [Related]
12. Acetaminophen psi parameter: a useful tool to quantify hepatotoxicity risk in acute acetaminophen overdose.
Chomchai S; Chomchai C; Anusornsuwan T
Clin Toxicol (Phila); 2011 Aug; 49(7):664-7. PubMed ID: 21819286
[TBL] [Abstract][Full Text] [Related]
13. Overdose with modified-release paracetamol (Panadol Osteo®) presenting to a metropolitan emergency medicine network: a case series.
Graudins A
Emerg Med Australas; 2014 Aug; 26(4):398-402. PubMed ID: 24934700
[TBL] [Abstract][Full Text] [Related]
14. Predicting acute acetaminophen hepatotoxicity with acetaminophen-aminotransferase multiplication product and the Psi parameter.
Chomchai S; Chomchai C
Clin Toxicol (Phila); 2014 Jun; 52(5):506-11. PubMed ID: 24844577
[TBL] [Abstract][Full Text] [Related]
15. Retrospective evaluation of repeated supratherapeutic ingestion (RSTI) of paracetamol
Egan H; Isbister GK; Robinson J; Downes M; Chan BS; Vecellio E; Chiew AL
Clin Toxicol (Phila); 2019 Aug; 57(8):703-711. PubMed ID: 30789042
[No Abstract] [Full Text] [Related]
16. Risk factors in the development of adverse reactions to N-acetylcysteine in patients with paracetamol poisoning.
Schmidt LE; Dalhoff K
Br J Clin Pharmacol; 2001 Jan; 51(1):87-91. PubMed ID: 11167669
[TBL] [Abstract][Full Text] [Related]
17. Hepatotoxicity induced by acute and chronic paracetamol overdose in children: Where do we stand?
Tong HY; Medrano N; Borobia AM; Ruiz JA; Martínez AM; Martín J; Quintana M; García S; Carcas AJ; Ramírez E
World J Pediatr; 2017 Feb; 13(1):76-83. PubMed ID: 27457792
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of intravenous N-acetylcysteine for acetaminophen overdose: analysis of the Hunter Area Toxicology Service (HATS) database.
Whyte IM; Francis B; Dawson AH
Curr Med Res Opin; 2007 Oct; 23(10):2359-68. PubMed ID: 17705945
[TBL] [Abstract][Full Text] [Related]
19. Acetaminophen overdose with altered acetaminophen pharmacokinetics and hepatotoxicity associated with premature cessation of intravenous N-acetylcysteine therapy.
Smith SW; Howland MA; Hoffman RS; Nelson LS
Ann Pharmacother; 2008 Sep; 42(9):1333-9. PubMed ID: 18628444
[TBL] [Abstract][Full Text] [Related]
20. Effect of acetylcysteine on prothrombin index in paracetamol poisoning without hepatocellular injury.
Schmidt LE; Knudsen TT; Dalhoff K; Bendtsen F
Lancet; 2002 Oct; 360(9340):1151-2. PubMed ID: 12387966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
